Being a leading viral vector and plasmid GMP manufacturing company, Vigene has joined the fight against COVID-19. We have 2020 GMP manufacturing slots now to help manufacture the vaccines for COVID-19 along the 3 categories.
- Adenovirus GMP production expressing certain COVID-19 antigen
- GMP AAV-delivered COVID-19 vaccine
- GMP Plasmid or Bacmid based COVID-19 vaccine
Vigene features 71,000 square feet and 10 new GMP suites to provide more opportunities for growth and innovation as the fields of gene and cell therapy continue to evolve.
- 5 GMP plasmid production suites
- 4 GMP viral vector production suites with up to 1000L capacity for adherent and suspension cell production
- 1 MCB production suite.
Contact us today to fight alongside with you against COVID-19.